Navigation Links
Veran Medical Technologies Announces Initial Shipment of SPiN Drive® Platform to Customers
Date:1/17/2012

ST. LOUIS, Jan. 17, 2012 /PRNewswire/ -- Veran Medical Technologies announced today that the Company has started initial shipments of its SPiN Drive® electromagnetic navigation platform, an advanced solution that biopsies peripheral Solitary Pulmonary Nodules (SPNs) for the potential early diagnosis of lung cancer. 

The SPiN Drive system design may improve efficiency and enhance workflow by allowing the physician to never lose or remove navigation at the time of biopsy with the Always-On Tip Tracked™ instruments. The platform is the first in electromagnetic navigation to provide optimal facility flexibility by requiring no unique bed or room calibration.  Additionally, the ability to view airways during procedures may provide a significant advantage toward targeting SPNs.

Targets are viewed on high-resolution CT images using a patient-specific view, without any radiation being delivered to the patient, physician or staff.  In addition, the SPiN Drive technology includes bi-planar virtual fluoroscopy view used to navigate multiple planes simultaneously.  This advancement is the first of its kind in pulmonology, enabling physicians to view the location of the Always-On Tip Tracked instrument. 

"The SPiN Drive platform is ground-breaking technology in electromagnetic navigation," said Gregg Smith, vice president of sales and marketing at Veran Medical Technologies.  "The SPiN Drive system has generated tremendous market excitement since its introduction.  As expected, hospitals looking to provide the most advanced electromagnetic navigation technology for early diagnosis of lung cancer are seeking the SPiN Drive platform.  We are excited about the interest in SPiN Drive and believe we are strongly positioned for growth in 2012."  

Lung cancer is a deadly disease that mortally claims 85 percent of patients within five years. According to the recent NLST (National Lung Screen Trial) study, there is a 21 percent reduction in mortality for patients screened for lung cancer.  Many SPNs in the peripheral lung are inaccessible with today's techniques and technologies, leaving patients on "watchful waiting" protocols of repeat CT scanning causing significant patient anxiety and unproductive costs added to the U.S. Healthcare System.  Veran's SPiN Drive product acts as a GPS-like system to enable pulmonologists and surgeons to access SPNs, aid in obtaining biopsy tissue for diagnosis and end watchful waiting. 

About Veran Medical Technologies, Inc. Veran Medical Technologies is a privately held company led by a team of innovators focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies.  Veran has built several clinical products upon its ig4™ platform technology, which uses proprietary 4D registration capabilities for targeting lesions within the human body.  The company believes that by enabling minimally invasive early stage diagnosis, it can increase patient survival and lower healthcare costs significantly.  Veran Medical Technologies is headquartered in St. Louis, MO.

 

 


'/>"/>
SOURCE Veran Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Technologies Launches New SPiN Drive™ Application for Bi-Planar Virtual Fluoroscopy View
2. Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System
3. VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System
4. Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy
5. The Market Outlook for Refurbished Medical Devices to 2016
6. Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Applications
7. Public Policy Staffing Study Offers Benchmark Opportunity for Bio-Pharma and Medical Device Companies
8. Arriva Medical Acquires Direct Diabetic Source
9. Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
10. Simbionix Comprehensive Medical Simulators now Available in Additional Languages
11. Suneva Medical to Pursue Expanded Indications for Artefill® With Launch of Phase III Acne Scar Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Physician General Dr. Rachel Levine ... Jennifer Smith commended South Central EMS today for ... naloxone, a life-saving overdose reversal drug. The recognition event ... and overdose survivor who was saved due to the ... significant part of fighting the opioid epidemic is making ...
(Date:2/24/2017)... , Feb. 24, 2017 Medical ... ways to increase their self-service capabilities to manage ... Providers (HCPs). New research from consulting ... organizations have developed self-service website portals where HCPs ... is just one of many findings to emerge ...
(Date:2/24/2017)... , Feb. 23, 2017 The U.S. ... the PhenoTest BC Kit, performed on the Pheno ... organisms that cause bloodstream infections and provide information ... respond to (antibiotic sensitivity). The test also reduces ... this important information, which can guide antibiotic treatment ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 2017 , ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer ... started as the Chairman of the Management Committee when IFN was originally formed in ... recruitment of investor/owners and development of the business plan. He became the first ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... qualifying into the Senior International Elite division on February 12th. Ms. Esparza ... divisions at the elite qualifier competition held in Las Vegas, Nevada. Frida is ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... Cranbury, NJ (PRWEB) , ... February 23, 2017 ... ... disease media outlet with a clinician-based audience, will be participating in Rare Disease ... 2017, in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter ...
(Date:2/23/2017)... ... ... Hamlin Dental Group and Dr. Hamid Reza, dentist in North Hollywood ... of February, patients who visit Hamlin Dental Group will receive a ticket for a ... the Cheesecake Factory. , Tickets are available for routine dental visits and other ...
Breaking Medicine News(10 mins):